Abhijit Lele &Amp;Amp; Ruchika Chitravanshi

Stories by Abhijit Lele &Amp;Amp; Ruchika Chitravanshi

After a year of Covid, India may not face a second wave

After a year of Covid, India may not face a second wave

Rediff.com   9 Feb 2021

Epidemiologists point out that if there is no second wave, it means that the number of infected has surpassed the uninfected, reports Ruchika Chitravanshi.

Despite Covid, registration of new companies went up in 2020

Despite Covid, registration of new companies went up in 2020

Rediff.com   24 Jan 2021

Moreover, 5,611 companies struck off earlier by the ministry of corporate affairs because of compliance-related lacunae, were registered again.

Trusts, societies have to register with MCA by April 1

Trusts, societies have to register with MCA by April 1

Rediff.com   23 Jan 2021

Corporate social responsibility rules that kicked in on Friday also set a three year time-limit for any CSR project, among a series of other amendments introduced by the government.

Covaxin has tolerable safety: Lancet

Covaxin has tolerable safety: Lancet

Rediff.com   23 Jan 2021

The vaccine was well tolerated in all dose groups with no vaccine-related adverse events.

Budget 2021: Sharper focus on health care likely

Budget 2021: Sharper focus on health care likely

Rediff.com   20 Jan 2021

CII has also called for tax incentives for new health care projects and import duty relief for lifesaving equipment.

Cash was king in 2020 even as digital transactions increased

Cash was king in 2020 even as digital transactions increased

Rediff.com   20 Jan 2021

The hoarding of cash accentuated from the very start of 2020, when the coronavirus pandemic started taking hold the world over, and fear of the pandemic prodded people to remain liquid for emergency use.

Govt proposes phase-wise pre-packed insolvency process

Govt proposes phase-wise pre-packed insolvency process

Rediff.com   18 Jan 2021

A draft proposal by the sub-committee of the insolvency law committee has recommended that the corporate debtor (CD) may initiate the prepack since it may prove difficult to implement if creditors are allowed to do so without the willingness of the promoter.

'Vaccine is far safer than getting Covid'

'Vaccine is far safer than getting Covid'

Rediff.com   16 Jan 2021

'I would go for Bharat Biotech's Covaxin and not Covishield, and that is my personal judgment since at least 11,500 have got at least one dose by now and it has proven to be safe.'

'Economy well placed to capitalise on recovery in 2021'

'Economy well placed to capitalise on recovery in 2021'

Rediff.com   6 Jan 2021

'The financial sector's performance in the first two quarters was a revelation.' 'It clearly showed the clean-up had been done in the past one-and-a-half years and that capital brought in was significantly stronger.'

COVID-19 Vaccine: Vial, syringe makers ramp up

COVID-19 Vaccine: Vial, syringe makers ramp up

Rediff.com   2 Jan 2021

'The government should put the whole road map together for the vaccine and decide how industry can support...' 'They should allow the private sector to vaccinate.'

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

Rediff.com   31 Dec 2020

The expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine.

From loan moratorium to digitisation, 2020 saw major shifts in banking

From loan moratorium to digitisation, 2020 saw major shifts in banking

Rediff.com   30 Dec 2020

While lenders create a hype around the services offered on digital platforms, customers think otherwise, given that frustration due to the quality of service has only increased, over the years.

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Rediff.com   29 Dec 2020

The Serum Institute of India has stockpiled 40 mn-50 mn doses and is adding more every week. Most of these will come to India.

Pros and cons of Indian banks' cross-selling initiatives

Pros and cons of Indian banks' cross-selling initiatives

Rediff.com   28 Dec 2020

In a bid to gain a bigger share of the customer's wallet, banks are ramping up their cross-selling initiatives.

Why it makes sense to take personal loans from PSBs

Why it makes sense to take personal loans from PSBs

Rediff.com   26 Dec 2020

The interest rate offered by PSBs like SBI, BoB and BoI hover around 8.9 per cent-10.50 per cent. For private banks, the range is between 10.49 per cent and 12 per cent.

'Unprecedented vaccine trial in India'

'Unprecedented vaccine trial in India'

Rediff.com   23 Dec 2020

Bharat Biotech recruited 13,000 participants for the Phase-3 clinical trial of Covaxin. This is one of the largest efficacy trials held in the country.

ATM-isation of banking is here

ATM-isation of banking is here

Rediff.com   22 Dec 2020

But what do banks gain by opening their apps for all? The answer -- rival bank's customers under their fold.

'Demand for home loans is rising steadily'

'Demand for home loans is rising steadily'

Rediff.com   19 Dec 2020

'We tightened our risk frameworks once the Covid crisis started.' 'We are slowly lightening this as we see economic activity pick up, salaries getting restored, and people getting back into jobs.'

COVID-19: How to get vaccinated

COVID-19: How to get vaccinated

Rediff.com   19 Dec 2020

For vaccination, online registration is mandatory. Thereafter, eligible beneficiaries will be informed on their registered mobile number about the nearest vaccination facility, and the date and time of vaccination.

More than 60% of bankruptcy proceedings led to liquidation in Q2

More than 60% of bankruptcy proceedings led to liquidation in Q2

Rediff.com   16 Dec 2020

Experts say this further underlines the lack of investor interest in stressed assets at present.